Notable Labs, Ltd. (NTBL)

USD 0.25

(-27.68%)

Market Cap (In USD)

2.39 Million

Revenue (In USD)

310 Thousand

Net Income (In USD)

-11.26 Million

Avg. Volume

91.99 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.22-4.24
PE
-
EPS
-
Beta Value
0.0
ISIN
IL0012002452
CUSIP
-
CIK
1603207
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Joseph P. Wagner Ph.D.
Employee Count
-
Website
https://www.notablelabs.com
Ipo Date
2014-10-01
Details
Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track clinical development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor for acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes indications; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. is headquartered in Foster City, California.